Your browser doesn't support javascript.
loading
Low levels of NMNAT2 compromise axon development and survival.
Gilley, Jonathan; Mayer, Paul R; Yu, Gang; Coleman, Michael P.
Afiliação
  • Gilley J; John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, E.D. Adrian Building, Forvie Site, Robinson Way, Cambridge, UK.
  • Mayer PR; Signalling Programme, Babraham Institute, Babraham Research Campus, Cambridge, UK.
  • Yu G; Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Coleman MP; Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Hum Mol Genet ; 28(3): 448-458, 2019 02 01.
Article em En | MEDLINE | ID: mdl-30304512
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Axônios / Nicotinamida-Nucleotídeo Adenililtransferase Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Axônios / Nicotinamida-Nucleotídeo Adenililtransferase Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article